Korean firm EuBiologics receives approval for Ph III trial of COVID-19 vaccine

Vaccines |  News | 0 Comment | 04 Feb, 2022

EuBiologics, a South Korean biotech company, has announced that EuCorVac-19, a COVID-19 vaccine candidate obtained appro...Read more

How IP Nitty-gritties Hinder Universal Immunisation?

Vaccines |  Analysis | By Ayesha Siddiqui | 1 Comment | 04 Feb, 2022

The coronavirus crisis which has enraged the world has also opened up debates around IP and public health.  The gen...Read more

Japan grants patent to Anixa Biosciences for ovarian cancer vaccine

Vaccines |  News | 0 Comment | 01 Feb, 2022

US-based Anixa Biosciences, Inc. has announced that the Japanese Patent Office has issued a Decision to Grant ...Read more

CEPI partners with BioNet to expand variant-proof vaccine programme

Vaccines |  News | 0 Comment | 01 Feb, 2022

CEPI, the Coalition for Epidemic Preparedness Innovations, has announced the latest award under its $200 million pr...Read more

Daiichi Sankyo starts trial for mRNA vaccine as booster dose in Japan

Vaccines |  News | 0 Comment | 31 Jan, 2022

Daiichi Sankyo has initiated a trial in Japan to investigate a booster dose of DS-5670, an mRNA vaccine against COVID-19...Read more

Australia approves Pfizer booster for 16–17 year olds

Vaccines |  News | 0 Comment | 28 Jan, 2022

The Therapeutic Goods Administration (TGA) in Australia has approved the Pfizer COVID-19 booster dose for young people a...Read more

National Vaccine Institute of Thailand strengthens partnership with International Vaccine Institute

Vaccines |  News | 0 Comment | 24 Jan, 2022

The International Vaccine Institute (IVI) in South Korea and the National Vaccine Institute (NVI) of Thailand have signe...Read more

Australia grants provisional registration for Novavax COVID-19 vaccine

Vaccines |  News | 0 Comment | 20 Jan, 2022

Novavax, Inc. has announced that Australia's Therapeutic Goods Administration (TGA) has granted approval for p...Read more

How countries are dealing with 'Vaccine Hesitancy'?

Vaccines |  Opinion | By Beau Peters, US | 2 Comment | 13 Jan, 2022

The COVID-19 pandemic may well be the worst public health crisis in modern history. But today, the global health system ...Read more

South Korea approves Novavax COVID-19 vaccine

Vaccines |  News | 0 Comment | 13 Jan, 2022

US-based Novavax, Inc. and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, have annou...Read more

Novavax, Serum Institute of India file for COVID-19 vaccine EUA in South Africa

Vaccines |  News | 0 Comment | 11 Jan, 2022

Novavax, Inc. and Serum Institute of India have announced a regulatory submission to the South African Health Products R...Read more

GSK Singapore launches Shingrix vaccine against shingles (herpes zoster)

Vaccines |  News | 0 Comment | 10 Jan, 2022

GlaxoSmithKline (GSK) Singapore has launched a new vaccine to help protect against shingles, Shingrix, in...Read more

Pfizer receives EUA of booster shot for 12-15 age group

Vaccines |  News | 0 Comment | 04 Jan, 2022

Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency U...Read more

India's COVAXINÒ exhibits safety in paediatric subjects in Ph II/III study

Vaccines |  News | 0 Comment | 03 Jan, 2022

Indian firm Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines...Read more

CEPI backs Korea to develop ‘variant-proof’ vaccine candidate

Vaccines |  News | 0 Comment | 22 Dec, 2021

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and South Korean firm SK bioscience (SK) have an...Read more

Japan approves booster shot for Moderna COVID-19 vaccine

Vaccines |  News | 0 Comment | 20 Dec, 2021

US-based Brand Institute has announced its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SP...Read more

Korea issues marketing authorization to Moderna COVID-19 vaccine

Vaccines |  News | 0 Comment | 16 Dec, 2021

American firm Moderna has announced that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing aut...Read more

HDT Bio initiates RNA COVID-19 vaccine trials in South Korea

Vaccines |  News | 0 Comment | 14 Dec, 2021

HDT Bio Corp., a US-based developer of immunotherapies for oncology and infectious diseases, and Korean biotech Quratis ...Read more